APA (7th ed.) Citation

Burcher, K. M., Lantz, J. W., Gavrila, E., Abreu, A., Burcher, J. T., Faucheux, A. T., . . . Porosnicu, M. (2021). Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma. Cancers, 13(22), 5733. https://doi.org/10.3390/cancers13225733

Chicago Style (17th ed.) Citation

Burcher, Kimberly M., et al. "Relationship Between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma." Cancers 13, no. 22 (2021): 5733. https://doi.org/10.3390/cancers13225733.

MLA (9th ed.) Citation

Burcher, Kimberly M., et al. "Relationship Between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma." Cancers, vol. 13, no. 22, 2021, p. 5733, https://doi.org/10.3390/cancers13225733.